These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20308377)

  • 1. Telbivudine exhibits no inhibitory activity against HIV-1 clinical isolates in vitro.
    Lin K; Karwowska S; Lam E; Limoli K; Evans TG; Avila C
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2670-3. PubMed ID: 20308377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telbivudine exerts no antiviral activity against HIV-1 in vitro and in humans.
    van Maarseveen NM; Wensing AM; de Jong D; Beilhartz GL; Obikhod A; Tao S; Pingen M; Arends JE; Hoepelman AI; Schinazi RF; Götte M; Nijhuis M
    Antivir Ther; 2011; 16(7):1123-30. PubMed ID: 22024528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early viral kinetics of telbivudine and entecavir: results of a 12-week randomized exploratory study with patients with HBeAg-positive chronic hepatitis B.
    Suh DJ; Um SH; Herrmann E; Kim JH; Lee YS; Lee HJ; Lee MS; Lee YJ; Bao W; Lopez P; Lee HC; Avila C; Zeuzem S
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1242-7. PubMed ID: 20028815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatitis B in patients with HIV infection].
    Barreiro P; Martín-Carbonero L; García-Samaniego J
    Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 7():71-9. PubMed ID: 19100234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telbivudine in the treatment of chronic hepatitis B: experience in HIV type-1-infected patients naive for antiretroviral therapy.
    Milazzo L; Caramma I; Lai A; Violin M; De Maddalena C; Cesari M; Galli M; Balotta C
    Antivir Ther; 2009; 14(6):869-72. PubMed ID: 19812451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the in vitro anti-HBV activity of clevudine in combination with other nucleoside/nucleotide inhibitors.
    Niu C; Bao H; Tolstykh T; Micolochick Steuer HM; Murakami E; Korba B; Furman PA
    Antivir Ther; 2010; 15(3):401-12. PubMed ID: 20516559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of telbivudine and entecavir for chronic hepatitis B in real-world clinical practice.
    Tsai MC; Lee CM; Chiu KW; Hung CH; Tung WC; Chen CH; Tseng PL; Chang KC; Wang JH; Lu SN; Yen YH; Hu TH
    J Antimicrob Chemother; 2012 Mar; 67(3):696-9. PubMed ID: 22174039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of telbivudine following oral administration of escalating single and multiple doses in patients with chronic hepatitis B virus infection: pharmacodynamic implications.
    Zhou XJ; Lim SG; Lloyd DM; Chao GC; Brown NA; Lai CL
    Antimicrob Agents Chemother; 2006 Mar; 50(3):874-9. PubMed ID: 16495245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Telbivudine treatment on cirrhosis resulting from chronic hepatitis B].
    Liang J; Han T; Xiao SX
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):24-7. PubMed ID: 19203447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telbivudine.
    Keam SJ
    Drugs; 2007; 67(13):1917-29. PubMed ID: 17722961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telbivudine, a nucleoside analog inhibitor of HBV polymerase, has a different in vitro cross-resistance profile than the nucleotide analog inhibitors adefovir and tenofovir.
    Seifer M; Patty A; Serra I; Li B; Standring DN
    Antiviral Res; 2009 Feb; 81(2):147-55. PubMed ID: 19028525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-hepatitis B virus activity in vitro of combinations of tenofovir with nucleoside/nucleotide analogues.
    Zhu Y; Curtis M; Qi X; Miller MD; Borroto-Esoda K
    Antivir Chem Chemother; 2009; 19(4):165-76. PubMed ID: 19374144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telbivudine in the treatment of chronic hepatitis B.
    Nash K
    Adv Ther; 2009 Feb; 26(2):155-69. PubMed ID: 19225726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telbivudine: a new nucleoside analogue for the treatment of chronic hepatitis B.
    Han SH
    Expert Opin Investig Drugs; 2005 Apr; 14(4):511-9. PubMed ID: 15882124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The efficacy and safety of telbivudine in korean patients with chronic hepatitis B].
    Moon YM; Hwang SG; Kim BS; Rim KS; Cho M; Kim DJ; Han JY; Kim YS; Choi HS; Ahn SH
    Korean J Hepatol; 2007 Dec; 13(4):503-12. PubMed ID: 18159148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B in HIV patients: what is the current treatment and what are the challenges?
    Soriano V; Tuma P; Vispo E; Labarga P; Fernández JV; Medrano J; Barreiro P
    J HIV Ther; 2009 Mar; 14(1):13-8. PubMed ID: 19731560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of switching to telbivudine in chronic hepatitis B patients treated previously with lamivudine.
    Safadi R; Xie Q; Chen Y; Yin YK; Wei L; Hwang SG; Zuckerman E; Jia JD; Lopez P
    Liver Int; 2011 May; 31(5):667-75. PubMed ID: 21040410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical management of patients with chronic hepatitis B virus infection].
    Rodríguez M; González-Diéguez ML
    Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 7():56-65. PubMed ID: 19100232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic hepatitis B: focus on telbivudine.
    Lui YY; Chan HL
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):259-68. PubMed ID: 19344240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nucleoside and nucleotide analogs in the treatment of chronic hepatitis B].
    Buti M
    Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 7():32-8. PubMed ID: 19100229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.